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Reciprocal repression of inner cell mass speciﬁc factor OCT4 and trophectoderm speciﬁc factor CDX2
promotes mouse ﬁrst lineage segregation. Studies in mouse embryonic stem (ES) cells revealed that they
bind to each other's regulatory regions to reciprocally suppress transcription, additionally they form
protein complex for mutual antagonism. However, so far the molecular interaction of Oct4 and Cdx2 in
other mammal's early embryo is not yet investigated. Here, over-expression of Cdx2 in early porcine
embryo showed CDX2 represses Oct4 through neither the transcriptional repression nor forming re-
pressive complex, but promoting OCT4 nuclear export and proteasomal degradation. The results showed
novel molecular regulation of CDX2 on Oct4, and provided important clues for clarifying the mechanism
of interaction between CDX2 and Oct4 in embryo of mammals other than mouse.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
POU family transcription factor OCT4 (encoded by Pou5f1) and
the homeodomain transcription factor CDX2 separately play core
roles in regulating inner cell mass (ICM) and trophectoderm (TE)
commitment. In blastocysts of mammals including mouse, human,
cattle and pig, Cdx2 is speciﬁcally expressed in the TE, while Oct4
is expressed in both ICM and TE for a short or long, species-speciﬁc
period and ﬁnally restricted to the ICM (Hall et al., 2009; Kirchhof
et al., 2000; Kuijk et al., 2008; Szczepanska et al., 2011; Yeom et al.,
1996). Oct4 or Cdx2 null mouse embryos die around implantation,
respectively due to dysfunctional ICM and TE (Blij et al., 2012; Le
Bin et al., 2014; Nichols et al., 1998; Strumpf et al., 2005; Wu et al.,
2013). In vitro, Oct4 over-expression represses Cdx2 transcription
in trophoblast stem (TS) cells and convert TS into embryonic stem
(ES) cells (Wu et al., 2011), while Cdx2 over-expression (Niwa
et al., 2005; Tolkunova et al., 2006), like Oct4 knockdown (Niwa
et al., 2000; Velkey and O’Shea, 2003), represses Oct4 transcription
in ES cells and induces its differentiation into TS cells.
Mutual antagonism between these two factors has been in-
vestigated in mouse ES cells ectopically expressing Cdx2 (Niwa
et al., 2005). In this study, the authors drew three mainconclusions: ﬁrst, Oct4 and Cdx2 play decisive roles in the cell fate
conversion between ES and TS/TE cells; second, Cdx2 and Oct4
reciprocally represses each other's gene transcription; third, CDX2
and OCT4 form a repressor complex that reciprocally represses
their target genes in ES cells. Thus, they proposed that reciprocal
inhibition between Cdx2 and Oct4 should contribute to the ﬁrst
differentiation event of mammalian embryonic development, due
to the co-expression of Cdx2 and Oct4 prior to blastocyst forma-
tion (Dietrich and Hiiragi, 2007), and their eventual speciﬁcation
in different domains, with CDX2 in the outer side cells – TE and
OCT4 in the inner side cells – ICM. Together with dysfunctional TE
and increased Oct4 expression in TE cells of Cdx2 deﬁcient mouse
blastocysts (Jedrusik et al., 2010; Strumpf et al., 2005; Wu et al.,
2010), the increased Cdx2 expression in Oct4 deﬁcient mouse
embryos (Wu et al., 2013) further conﬁrmed that molecular in-
teraction between Cdx2 and Oct4 in early embryos is critical to
ICM and TE segregation. In contrast to mouse, very few studies
were carried out in other mammals to explore the molecular
mechanisms underlying ﬁrst lineage segregation. It is clear now
that Cdx2 possesses restricted expression in TE cell of almost all
the tested mammals, and Oct4 strongly expresses in ICM. How-
ever, existing Cdx2 knockdown studies, one in monkey and one is
cattle warned us that the molecular interaction between Cdx2 and
Oct4 in these species’ early embryos might be different from
mouse, because Cdx2 knockdown has failed to elevate Oct4 tran-
scription in blastocysts (Berg et al., 2011; Jedrusik et al., 2010;
Sritanaudomchai et al., 2009). Consistently, we also found that
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mRNA level at blastocyst stage. Moreover, Oct4 has longer period
expression in TE cells of some species like cattle, pig, even human
(Cauffman et al., 2005; Chen et al., 2009; Hall et al., 2009; Kirchhof
et al., 2000; van Eijk et al., 1999). Berg et al. (2011) found that the
loss of Tcfap2 binding site in upstream regulatory sequences of
cattle Oct4 gene accounts for its prolonged expression TE cells,
while in mouse, transcription factor Tcfap2 can mediate a Cdx2-
independent repression of Oct4 in TE cells. All these collectively
implied that in early development of different mammalian species,
there is diversity in molecular regulation of core genes like Cdx2
and Oct4. It is believed that more understanding on the regulation
and interaction of Cdx2 and Oct4 in early development of mam-
mals other than mouse will enrich our knowledge about mam-
malian embryonic development (Rossant, 2011). Therefore, to ex-
plore the regulatory interaction between Cdx2 and Oct4 in early
porcine embryos, we studied the regulatory effects of Cdx2 over-
expression on Oct4 expression and function during early devel-
opment. Previous study in mice over-expressing a Cdx2 transgene
under the control of its own promoter did not ﬁnd any remarkable
changes in early embryonic development, but rather a shift in axial
patterning during later stages (Gaunt et al., 2008). Additionally,
they did not investigate the effect of Cdx2 on Oct4 expression in
early embryos. It is possible that ectopic Cdx2 driven from its own
promoter is not expressed robustly in early embryos and does not
yield any effects until the 16-cell stage, when its natural expres-
sion is elevated (Jedrusik et al., 2010; Wu et al., 2010). Thus, in the
present study, we used the method of quantitative injection of
Cdx2mRNA into porcine early embryos to facilitate investigation of
the regulatory effects of Cdx2 on Oct4. To our knowledge it is the
ﬁrst time that the molecular interaction of Cdx2 and Oct4 has been
investigated in early mammalian embryos, and our results shed
light on a new model involving Oct4 and Cdx2 interaction in
porcine embryo just before ICM and TE lineage segregation.2. Material and methods
2.1. Recovery and culture of porcine oocytes, in vitro fertilization (IVF)
procedures, and embryonic culture
Ovaries were collected from a slaughterhouse and transported
to lab in 0.9% saline at 37 °C. Follicles 3―5 mm in diameter was
aspirated to obtain cumulus–oocyte complexes. Oocytes were
matured as previously described (Liu et al., 2008). Animal work
followed the guidelines of Animal Care and Use Committee of the
Northeast Agricultural University. IVF and embryonic culture were
same as previously described (Bou et al., 2014).
2.2. siRNA and mRNA production and injection into porcine zygotes
For overexpression via mRNA injection, Cdx2 (936 bp, with pri-
mers: F:ATGTACGTGAGCTACCTCCTGGACAAGGAC; R:CTGGGTGAC-
GGTGGGGTTTAACACGC) and Oct4 (1083 bp, with primers: F:
ATGGCGGGACACCTGGCTTCCG; R:TCAGTTTGAATGCATGGGGGAGC),
their full-length ORF of DNA construct were cloned from cDNA of
porcine blastocyst with PCR method and inserted into MCS of pMACS
Kk.HA. (N) plasmid backbone (Miltenyi Biotec). To obtain the domi-
nant negative mutated Oct4 mRNA, after adding a heterogeneous
nuclear localization signal (NLS) in MCS behind C-terminal of Oct4 in
pMACS Kk.HA. (N)-Oct4 plasmid, the targetedmutation in original NLS
was generated by PCR-based site-directed mutagenesis through am-
plifying the pMACS Kk.HA. (N)-Oct4-NLS plasmid with primers bear-
ing mutations (F:CCAGAGTCGACACAAGTATCGAGAAC; R:AAAGTC-
GACTCTGGATCCGGCCTGCACGAGGGT). As a control, EGFP (702 bp, F:
ATGGTGAGCAAGGGCGAGGAGCT; R:TCACTTGTACAGCTCGTCCATGCC-GAG) was cloned from pEGFP-C1 plasmid by PCR method and con-
structed into pMACS Kk.HA. (N) plasmid. The full-length Cdx2, Oct4,
dnOct4 and EGFP mRNA were synthesized in vitro using RIBOMAX
Large Scale RNA Production System T7 kit (Promega) and according to
the manufacture's instruction followed by the quality assessment via
gel analysis.
To deplete porcine Oct4, the online tool BLOCK-iT RNAi De-
signer was used to design Stealth siRNA. Two Oct4 speciﬁc Stealth
RNAi oligonucleotides and one scrambled siRNA duplex as control
were used in this study (Osi1: F:UCGAACAAUUUGCC-
AAGCUCCUAAA; R:UUUAGGAGCUUGGCAAAUUGUUCGA; Osi2: F:
GGCAAACGAUCAAGCAGUGACUA
UU; R:AAUAGUCACUGCUUGAUCGUUUGCC; Scrambled siRNA:
F:GGCCAAGCUAACGGAGUCAUAAAUU; R:AAUUUAUGACUCCGU-
UAGCUUGGCC). Then siRNA and mRNA microinjections were car-
ried out with an Eppendorf FemtoJet microinjector and Narishige
NT-88NE micromanipulators. For injection, glass capillary femtotip
II (Eppendorf) was loaded with 5 μl of RNA (siRNA: 20 nM) by
microloader (Eppendorf), and about 30 pl of solution was injected
into the cytoplasm of porcine zygotes.
2.3. RNA preparation and quantitative PCR (qPCR)
RNA was extracted with PureLink Micro-to-Midi total RNA
puriﬁcation kit (Invitrogen) and reverse transcribed with the High
capacity cDNA reverse transcription kits (Applied BioSystems)
using random primers or the First strand cDNA kit (Fermentas) for
gene speciﬁc primers (Cdx2 speciﬁc RT primer: R:ATCTCCT-
TACTGGCAGAAGGTCAG; Oct4 speciﬁc RT primer: R:TCAA-
GAGCATCATTGAACTTCACC). SYBR Premix Ex Taq for Perfect Real
Time (Takara) was used for qPCR with oligonucleotide primers
(Oct4 qPCR: 163 bp, F:GAAGCTGGACAAGGAGAAGCTGGAG; R:
ATGGTCGTTTGGCTGAACACCTTC; Cdx2 qPCR: 117 bp, F:AGTCGC-
TACATCACCATTCGGAG; R:GCTGCTGTTGCTGCAACTTCTTC; 18 S
rRNA qPCR: 149 bp, F:TCCAATGGATCCTCGCGGAA; R:GGCTACCA-
CATCCAAGGAAG). Data from three replicates were analyzed by ΔΔ
Ct method after normalization with 18 s rRNA level (Kuijk et al.,
2007).
2.4. MG132 treatment of porcine embryos
0.5 μl of 5 mM MG132 (carbobenzoxyl leucinyl leucinyl leuc-
inal-Hl, at a ﬁnal concentration of 5 μM) was added into 500 μl
culture medium of one day post fertilization embryos. Then after
24 or 48 h, the embryos were collected for further WB or IF ana-
lysis. The MG132 was dissolved in dimethyl sulfoxide (DMSO),
thus the control embryos were supplemented with the same
amount of DMSO.
2.5. Immunoﬂuorescence assays (IF) and Western blot (WB) assay
IF and WB was conducted in conventional procedures (Xu et al.,
2009a). Quantity One software (BioRad) was used to analyze the
results. Primary antibodies include mouse monoclonal to Cdx2
(MU392A-UC, Biogenex, IF: 1:50, WB: 1:200); goat polyclonal to
Oct4 (N19) (sc-8628, Santa Cruz, IF: 1:50, WB: 1:200); mouse
monoclonal to Beta-Actin (A1978, Sigma, WB: 1:500).
2.6. Co-immunoprecipitation (Co-IP)
Co-IP experiments were performed using the Pierce Co-Im-
munoprecipitation Kit (26149, Pierce) as per the manufacturer's
instructions. Brieﬂy, embryo lysates were then applied to columns
containing 1 mg immobilized antibodies (Rabbit polyclonal to HA
tag: ab9110, Abcam, IF: 1:1000, Co-IP: 1 μg per column or rabbit
IgG: A7016, Beyotime, Co-IP: 1 μg per column) covalently linked to
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immunoprecipitate was then eluted and analyzed by western blot
along with the input controls. For crosslinking treatment, as de-
scribed previously (Jaken and Parker, 2000), before embryos were
lysated, they were incubated with 2 mM dithiobis [succinimidyl-
propionate] DSP (Pierce) in PBS for 2 h at 4 °C and crosslinking was
terminated with 20 mM Tris HCl pH 8.0.
2.7. Statistical analysis
Each experiment was repeated at least three times and for
image results, a representative one is shown in our ﬁgures. The
data are presented as the means7s.d. One-way ANOVA was used
to determine statistical signiﬁcance. Differences that are shown
with “*”, or different letters like “a,b,c..” in our results represent
statistic signiﬁcance at a value of po0.05.3. Results and discussion
3.1 Cdx2 over-expression leads to arrested development in porcine
embryos
To over-express Cdx2, we injected in vitro transcribed HA–Fig. 1. HA-tagged Cdx2 mRNA injection into porcine zygote compromises embryonic dev
of HA tagged porcine Cdx2 mRNA. (B) Co-IF staining of CDX2 and HA-tag shows that HA t
the nucleus of 2-cell stage porcine embryo after zygote injection. (C) Cdx2 over-expressi
inside bars indicate the sample volume. Bar, 50 μm. (D) Representative status of 6.5 d
difference at po0.05. Numbers embedded in bars are the sample volume. EaBl: early blatagged, polyadenylated porcine Cdx2 mRNA (Fig. 1A) into porcine
zygotes. IF assay showed that the immunoreactive signal for CDX2
and HA-tag could be detected in the nucleus of 2-cell stage em-
bryos (Fig. 1B). Then we over-expressed Cdx2 by injecting its
mRNA at three different concentrations (5, 50 and 100 ng/μl) into
porcine zygotes and culturing the embryos for 6.5 days. As a result
(Fig.1C and D), Cdx2 over-expression induced developmental ar-
rest in a concentration dependant manner.
3.2 Cdx2 over-expression led to cleavage stage arrest via Oct4
repression
Normally porcine OCT4 has a stable and uniform expression
pattern in all blastomeres of cleavage stage embryos, and its ex-
pression levels in ICM and TE appear an evident difference after
hatched blastocysts stage (Fig. 2A). However, in Cdx2 over-ex-
pressing embryos (50 ng/μl), IF assays (Fig. 2B) showed a gradual
loss of nuclear OCT4 from the 2-cell to 8-cell stage.
Thus, we ﬁrst tested that if Oct4 knockdown alone could
compromise the development of the early porcine embryos. In our
study, zygotic injection of siRNA mix (Osi1þ2) composed of two
siRNAs (Osi1 and Osi2) targeting different sites on the porcine
Oct4 mRNA efﬁciently repressed Oct4 expression in early stage
porcine embryos (Fig. 2C and D) and, also decreased theirelopment. (A) The plasmid construct of pMACS kK. HA(N)-Cdx2 for in vitro synthesis
agged porcine Cdx2 mRNA has been correctly translated and CDX2 transported into
on impairs porcine embryonic development in a dose-dependent manner. Numbers
ays embryos after Cdx2 over-expression. n between bars indicates the signiﬁcant
stocyst; ExBL: expanded blastocyst; HaBL: hatched blastocyst; OE: over-expression.
Fig. 2. Loss of OCT4 is the main cause of Cdx2 over-expression induced developmental arrest. (A) IF assay shows the temporal and spatial pattern of Oct4 expression in pre-
implantation porcine embryos. Bar, 50 μm. (B) Co-IF staining of CDX2 and OCT4 shows that Cdx2 over-expression (50 ng/μl) induces gradual OCT4 loss in the nucleus of
porcine early stage embryos. Bar, 50 μm. (C) qPCR analysis of Oct4 mRNA level in 4-cell stage embryos after Oct4 knockdown via siRNA injection. (D) Co-IF of OCT4 and CDX2
after Oct4 knockdown. Bar, 50 μm. (E) Representative status of 6.5 days embryos after Oct4 knockdown. Bar, 500 μm. (F) Oct4 knockdown induces developmental arrest by
the 8-cell stage. (G) Co-injection of Oct4 mRNA with Cdx2 mRNA largely rescues embryonic development. For F and G, numbers above bars indicate the sample volume. n
between bars indicates the signiﬁcant difference at po0.05.
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Fig. 3. CDX2 repression on Oct4 in early porcine embryos. (A) and (B) CDX2 does not repress Oct4 transcription in early embryos: the experiment (A) to conduct qPCR of total
cDNA and gene speciﬁc ﬁrst strand cDNA subsequently shows that Cdx2 over-expression in cleavage stage embryos does not down regulate Oct4 mRNA compared with the
control group (B). RT, reverse transcription. (C) Comparison of Oct4 mRNA levels in early porcine embryos cultured with or without Amanitin treatment. n between bars
indicates the signiﬁcant difference at po0.05. (D) After 24 h proteasome inhibitor MG-132 treatment, both control and experimental group develop normally into 4/8-cell
stage (bar, 500 μm), which shown in statistics as (E). (F) CDX2 represses Oct4 post-translationally in early embryos. WB result shows that the treatment with proteasome
inhibitor MG132 robustly inhibits OCT4 degradation in Cdx2 over-expressing early porcine embryos. Different letters like “a,b,c..” represent statistic signiﬁcance at a value of
po0.05. (G)–(M) CDX2 promotes OCT4 nuclear to cytoplasmic translocation in early embryos. CDX2 and OCT4 immunostaining of embryos zygotically injected with low and
high concentrations of Cdx2 mRNA and then treated with MG132 are represented (G) and analysis of the nuclear ﬂuorescence intensities (H) was carried out. CRM-1
inhibitor LMB can effectively inhibit the loss of nuclear OCT4 that induced by Cdx2 over-expression (L) and analysis of the nuclear OCT4 ﬂuorescence intensities (M) was
carried out. In (H), (M), different letters like “a,b,c..” represent statistic signiﬁcance at a value of po0.05, numbers embedded in bars are the sample volume. In (G), (L), bar:
50 μm. (N) IF result shows widespread co-localization of CDX2 and OCT4 within the nucleus of Cdx2 over-expressing blastomere, except in the heterochromatic regions.
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F). Moreover, we found that the co-injection of Oct4 mRNA could
rescue the development of Cdx2 over-expressing embryos. As
shown in Fig. 2G, when the ratio of co-injected Oct4 and Cdx2 is
1:1, Oct4 could hardly change the compromised embryonic de-
velopment induced by Cdx2 overexpression. However when the
ratio of co-injected Oct4 and Cdx2 is raised to 4:1, Oct4 could even
totally rescue the embryonic development to a normal level.
All these results suggested that Cdx2 over-expression com-
promised embryonic development by decreasing OCT4 level in
early porcine embryos. Thus, it became possible that further ana-
lysis on the underlying mechanism for Oct4 repression in Cdx2
over-expressing porcine embryos will help us ﬁgure out the Cdx2
regulation on Oct4 in early porcine embryos.
3.3 CDX2 represses Oct4 post-translationally rather than tran-
scriptionally in early porcine embryos
It was proposed that (Niwa et al., 2005) in mouse ES cells and
early development, Cdx2 represses Oct4 in at least two ways,
(1) transcriptional repression by direct binding to the upstream
regulatory region of Oct4; (2) functional inhibition by forming a
CDX2-OCT4 protein complex that tends to localize to tran-
scriptionally inactive regions of the nucleus. Thus, we ﬁrst tested
that if Cdx2 over-expression in early porcine embryos induced a
decrease in Oct4 transcriptional level as in mouse ES model. Be-
cause evidences indicated that many genes, including Oct4 possess
natural antisense transcripts (Hawkins and Morris, 2010), thus, to
eliminate the potential inﬂuence of antisense transcripts in qPCR
assays, we used two methods to generate cDNA template: random,
and gene speciﬁc primers to initiate cDNA synthesis from total
RNA populations (Fig. 3A). However, regardless of the above
method, indeed we didn’t ﬁnd the decrease of Oct4mRNA levels in
Cdx2 over-expressing porcine embryos as compared with control
embryos (Fig. 3B) through assessing Oct4 mRNA levels in Cdx2
over-expressing 4- and 8-cell stage embryos.
Considering porcine major zygotic genome activation starts at
the 4- to 8-cell stage (Jarrell et al., 1991), and, thus, Oct4 mRNA at
the 4- and 8- cell stage might be maternal, to conﬁrm the starting
time of embryonic Oct4 transcription, we treated the embryos
from the zygote stage with 20 ng/μl ɑ-Amanitin (RNA polymerase
II inhibitor) and assessed Oct4 mRNA level at the 2-, 4- and 8-cell
stage. As shown in Fig. 3C, the maternal Oct4 mRNA is lost during
the 2- to 4-cell stage, and the transcription of embryonic Oct4 has
been primed at 4-cell stage. Thus, from the 4-cell stage onwards,
Oct4 mRNA level largely if not totally represents embryonic Oct4
transcriptional levels.
Cumulatively, these results indicate that Cdx2 over-expression
does not repress Oct4 transcription in early porcine embryos. It is
distinct from the result in mouse, that in ES cells, Cdx2 over-ex-
pression signiﬁcantly reduced Oct4mRNA levels within 48 h (Niwa
et al., 2005; Tolkunova et al., 2006). The difference suggests that
Cdx2 is not involved in Oct4 transcriptional repression in early
porcine embryos. Moreover, it is noteworthy that Oct4 mRNA le-
vels did not increase in Cdx2 deﬁcient mouse (Jedrusik et al.,
2010), monkey (Sritanaudomchai et al., 2009), bovine (Berg et al.,
2011) and porcine embryos.
To further test the possibility that CDX2 inhibits Oct4 at the
protein level, we treated embryos with MG132, a proteasome in-
hibitor, to block OCT4 degradation and then assessed OCT4 protein
levels in Cdx2 over-expressing embryos (zygotic injection of Cdx2
and Egfp mRNA) and control embryos (injected with Egfp mRNA
alone). Fig. 3D and E showed that 24 h, 5 nM MG132 treatment of
embryos since 24-h post fertilization did not induce any remark-
able developmental abnormalities in either the Cdx2 over-ex-
pressing or control embryos. WB assay (Fig. 3F) further showedthat compared with control embryos, without MG132 treatment,
the OCT4 protein levels in Cdx2 over-expressing embryos was
reduced drastically; however, application of MG132 could restore
OCT4 levels in Cdx2 over-expressing embryos. The disparity in the
OCT4 levels between untreated groups indicates that OCT4 protein
was degraded in Cdx2 over-expressing embryos. While the com-
parable OCT4 levels between the two MG132 treated groups re-
futes the possibility that CDX2 decreases OCT4 level by blocking
translation process. OCT4 degradation mediated by proteasome
has been reported in mouse ES cells (Xu et al., 2009b), but the
effect of Cdx2 over-expression on OCT4 degradation has not been
investigated in mouse. Our results suggested that in early porcine
embryos, CDX2 represses Oct4 at the post-translational level by
inducing proteasomal degradation of OCT4, rather than repressing
its transcription and translation.
3.4 CDX2 promotes OCT4 nuclear to cytoplasmic translocation in
early porcine embryos
It was reported that increasing OCT4 nuclear export could in-
duce its proteasomal degradation (Lin et al., 2012). Similar me-
chanisms have also been described for other transcription factors
(Yang et al., 2014), including SOX2 and NANOG. Thus, we analyzed
CDX2 and OCT4 in 4–8 cell stage embryos that were injected with
low (5 ng/μl) or high (100 ng/μl) concentration of Cdx2 mRNA at
the zygote stage and treated with MG132 since 24-h post fertili-
zation. As shown in Fig. 3E, at 4-cell stage, regardless of the Cdx2
mRNA concentration the ﬂuorescence intensity of cytoplasmic
OCT4 increased compared with the intact group. And then, at
8-cell stage, high concentrations of Cdx2 mRNA made CDX2
dominant in the nucleus and the nuclear OCT4 signal reduced
obviously. Fluorescence intensity analysis based on nuclear CDX2
and OCT4 immunoreactive signals (Fig. 3G and H) further con-
ﬁrmed a signiﬁcant loss of nuclear OCT4 with high levels of Cdx2
over-expression (po0.05). Combined with the WB result above
(Fig. 3F) that the levels of total OCT4 protein in Cdx2 over-ex-
pressing embryos and control embryos are comparable after
MG132 treatment, the loss of nuclear OCT4 further indicated that
Cdx2 over-expression promoted OCT4 nuclear to cytoplasmic
translocation. The remarkable increase in ﬂuorescence intensity of
cytoplasmic OCT4 signals in MG132 treated Cdx2 over-expressing
embryos (Fig. 3G) reinforced these ﬁndings. It was shown that
Oct4 can be exported from the nucleus via a mechanism that in-
volves the export factor CRM1 (also known as exportin1) (Lin
et al., 2012). Thus, to further prove that CDX2 induced OCT4 de-
gradation by promoting OCT4 nuclear to cytoplasmic translocation
in early embryos, we assumed the treatment with CRM1 inhibitor
Leptomycin B (LMB) can block the OCT4 nuclear export and thus
alleviating the decrease in nuclear OCT4 after Cdx2 over-expres-
sion. Consistent with our assumption, LMB signiﬁcantly inhibited
the loss of nuclear OCT4 in Cdx2 over-expressing 4-cell stage
porcine embryos (Fig. 3L and M (po0.05)). Thus taken together,
our results established that CDX2 promoted OCT4 nuclear to cy-
toplasmic translocation, which facilitating the cytoplasmic de-
gradation of OCT4.
The dosage-dependent effect of CDX2 on OCT4 nuclear export
shown above might explain the disparity in developmental out-
comes after low (5 ng/μl) and high (100 ng/μl) concentrations of
Cdx2 mRNA were injected (Fig. 1D) and suggested that the effec-
tiveness of CDX2 induced nuclear to cytoplasmic translocation is
dependent on the CDX2 to OCT4 ratio.
3.5 We did not ﬁnd evidence for a direct Cdx2–Oct4 interaction
In mouse studies, there was no evidence of CDX2 induced OCT4
nuclear to cytoplasmic translocation, but in mouse ES cells, it is
G. Bou et al. / Developmental Biology 410 (2016) 36–4442reported that CDX2 executes a functional inhibition via forming
CDX2–OCT4 protein repressor complex with biased localization to
transcriptionally inactive regions (judged by the high-density of
Hoechst staining) of the nucleus (Niwa et al., 2005). To exam if this
kind of functional inhibition exists in early porcine embryos, we
also observed CDX2 and OCT4 distribution in the nucleus (Fig. 3N).
Unlike the study in mouse ES cells, high resolution images indicate
Cdx2 expression did not induce a remarkable translocation of
OCT4 to high-density Hoechst staining heterochromatic regions in
interphase embryonic cells, even though a portion of CDX2 has
already localized on these regions. Moreover, using conventional
Co-IP procedures to capture strong, naturally occurring protein
complexes, we failed (n¼5, data not shown) to co-im-
munoprecipitate OCT4 and CDX2 with an anti-HA antibody in HA-
tagged Cdx2 mRNA injected 4–8 cell stage embryos. These resultsFig. 4. In early embryos, CDX2 might reduce OCT4 DNA accessibility by competing prox
CDX2 and OCT4 cross-linking co-IP assays. (B) Comparison between mouse (m) and por
introduced into porcine OCT4 was illustrated. (C) Representative status of 6.5 days embr
effect of Cdx2 over-expression on embryonic development. wt: wild type, dn: dominan
embedded in bars are the sample volume. (E) Model based on our results is demonstrat
embryos, especially before the ﬁrst lineage segregation.suggested that unlike the proposed model in mouse, the formation
of a CDX2-OCT4 repressor complex is not involved in Cdx2
mediated Oct4 regulation in early porcine embryos.
3.6 In early porcine embryos, CDX2 might reduce OCT4 DNA acces-
sibility by competing proximal binding sites, and thus reducing its
stability in nucleus
Unexpectedly, OCT4 and CDX2 were successfully co-im-
munoprecipitated with an anti-HA antibody in Cdx2 over-ex-
pressing 4–8 cell stage porcine embryos after DSP cross-linking
treatment (Fig. 4A). DSP is a long-arm cross-linker able to cross-
link proteins at distances of up to 12 Å, and has been used to
identify proteins attached indirectly by binding DNA or other
protein(s) (Fleurie et al., 2014; Qualmann et al., 2000). Consideringimal binding sites, and thus reducing its stability in nucleus. (A) Positive result of
cine (p) OCT4 amino acid sequences shows a high degree of identity. The mutation
yos of different groups. Bar, 500 μm. (D) Injection of dnOct4 mRNA recapitulates the
t negative. n between bars indicates the signiﬁcant difference at po0.05. Numbers
ing the way how Cdx2 regulates Oct4 in a non-ES cell manner in mammalian early
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homochromatic regions by IF assay (Fig. 3L), our results indicate
that although there is no direct binding between CDX2 and OCT4,
a portion of CDX2 and OCT4 are in close proximity in the nucleus
of Cdx2 over-expressing embryos.
Recent creative experiments with ﬂuorescence decay after
photoactivation assays showed that in early mouse embryonic
blastomeres, the OCT4 nuclear import and export kinetics is as-
sociated with its bias to ICM/TE cell fates (Pantazis and Bollenbach,
2012; Plachta et al., 2011), which depends on the accessibility of
OCT4 to its DNA binding sites in nucleus (Kaur et al., 2013; Plachta
et al., 2011). It has been shown that over-expression of Sox17
(another transcription factor responsible for extraembryonic line-
age speciﬁcation and has DNA binding sites similar/adjacent with
OCT4) made OCT4 in early mouse embryos display faster kinetics
and a low nuclear stabilized fraction because expressing excess
SOX17 may reduce the fraction of OCT4 bound to chromatin
(Plachta et al., 2011). CDX2 binding sites were found in proximity
to OCT4 binding sites, involving in regulation of Xist (Erwin et al.,
2012). Thus, incorporating these embryonic observations with our
results that substantial OCT4 and CDX2 could be cross-linked and
captured together, we hypothesized that one of the mechanisms
whereby CDX2 de-functionalizes and expels nuclear OCT4 is
weakening OCT4’s DNA accessibility through binding to proximal
genomic sites.
According to our hypothesis, any kind of competition of OCT4-
binding site should induce the effects of Cdx2 over-expression on
porcine embryonic development. Thus, we injected a dominant
negative (dn) transcript of porcine Oct4 including a mutated code
for NLS, which is reported in mice to code protein with the normal
POU and HD domains needed for protein interaction, DNA binding
and an exogenous NLS for nuclear localization but lacking a
functional transactivation domain (Pan et al., 2004), into porcine
embryos to compete wtOCT4. Amino acid sequence of the dnOCT4
is shown in Fig. 4B. If our hypothesis is tenable, this type of
dnOCT4 shall recapitulate the Cdx2’s effects on early embryos.
Thus, after conﬁrming the ability of this dnOCT4 to be correctly
translated and translocated into nucleus through transfection of its
mRNA into H293T cell (Data not shown), we injected its mRNA
(50 ng/μl) with Egfp mRNA (50 ng/μl) into porcine zygotes. Similar
to the effects of Cdx2 over-expression, increasing numbers of
embryos arrested when compared to those embryos injected with
only Egfp mRNA (100 ng/μl) or the mix of wtOct4 mRNA (50 ng/μl)
and Egfp mRNA (50 ng/μl) (Fig. 4C and D). These results provided
indirect support for the notion that in early porcine embryo, CDX2
could weaken DNA accessibility of OCT4 partially if not totally
through competing for adjacent binding sites in the nucleus, and
being the reason for CDX2 induced OCT4 nuclear export.4. Conclusion
The interaction of Cdx2 and Oct4 has been thoroughly studied
in mouse and recognized as two core transcription factors essen-
tial to ﬁrst lineage segregation. However, many evidences from
studies in mammals other than mouse indicated that molecular
interactions and regulation of Cdx2 and Oct4 might change across
different species. Given that Cdx2 and Oct4 interaction has not
been purposely investigated in porcine embryo, in this study we
investigated Cdx2 and Oct4 interaction in in vitro porcine embryos.
Our results indicate that in early porcine embryos, Cdx2 represses
Oct4 in a novel pattern (Fig. 4E): High ratio of Cdx2:Oct4 after
Cdx2 over-expression in early porcine embryos can post-transla-
tionally repress Oct4, mainly via increasing its nuclear export and
subsequent degradation by proteasome in cytoplasm. Further we
found that the changes on the OCT4 nuclear export is not achievedby forming a repressor complex, rather it might be promoted by
CDX2-mediated reduction in the DNA binding ability of OCT4
through competing proximal binding sites in chromatin. Our
ﬁndings are the ﬁrst demonstration of a mechanism by which the
OCT4 levels and function are regulated by CDX2 in early porcine
embryos, especially before ICM-TE segregation.Acknowledgment
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